Xiaofei Wang – författare

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials.

The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.

In the past decades, quotation theories have developed roughly along three lines—quotation types, meaning effects, and theoretical orientations toward the semantics/pragmatics distinction. Currently, whether the quoted expression is truth-conditionally relevant to the quotational sentence, and if there is a truth-conditional impact, whether it is generated via semantic or pragmatic processes, have become the central concerns of quotation studies.

In this book, quotation is clearly defined for the first time as a constituent embedded within yet distinctive from the quotational sentence. Also, as the first monograph to address the semantics/pragmatics boundary dispute over quotation, it argues that the semantic content of quotation amounts to its contribution to the intuitive truth-conditional content of the quotational utterance via two modes of presentation, which are incarnated in the functioning of quotation marks and manifested as use and mention. The use/mention-based analysis in this book can shed light on the semantic theorizing of other metalinguistic phenomena, while the semantics/pragmatics perspective will provide methodological implications for other relevant studies.

The new conception of quotation and thought-provoking analysis on use/mention, truth-conditional pragmatics, and the semantics/pragmatics boundary in this book will appeal to scholars and students in philosophy of language and linguistics. It will also serve as a clear guide to the current state of quotation studies and how to formulate a semantic theory of quotation.

In the past decades, quotation theories have developed roughly along three lines—quotation types, meaning effects, and theoretical orientations toward the semantics/pragmatics distinction. Currently, whether the quoted expression is truth-conditionally relevant to the quotational sentence, and if there is a truth-conditional impact, whether it is generated via semantic or pragmatic processes, have become the central concerns of quotation studies.

In this book, quotation is clearly defined for the first time as a constituent embedded within yet distinctive from the quotational sentence. Also, as the first monograph to address the semantics/pragmatics boundary dispute over quotation, it argues that the semantic content of quotation amounts to its contribution to the intuitive truth-conditional content of the quotational utterance via two modes of presentation, which are incarnated in the functioning of quotation marks and manifested as use and mention. The use/mention-based analysis in this book can shed light on the semantic theorizing of other metalinguistic phenomena, while the semantics/pragmatics perspective will provide methodological implications for other relevant studies.

The new conception of quotation and thought-provoking analysis on use/mention, truth-conditional pragmatics, and the semantics/pragmatics boundary in this book will appeal to scholars and students in philosophy of language and linguistics. It will also serve as a clear guide to the current state of quotation studies and how to formulate a semantic theory of quotation.

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials.

The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.

This volume set constitutes the proceedings of the 7th EAI International Conference on 6GN for Future Wireless Networks, 6GN 2024, held in Chongqing, China, in October 19-20, 2024.

The 18 papers included in these proceedings were carefully reviewed and selected from50 submissions.They focus on the following topical sections such as Wireless Control and Network Optimization; Edge Computing and Resource Allocation; Intelligent Systems and Simulation; Artificial Intelligence and Digital Economy.